WATCH: Moderna COVID-19 vaccine set for approval in U.S. with panel endorsementHealth Updated on Dec 17, 2020 5:34 PM EDT Published on Dec 16, 2020 9:18 PM EDT
WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
Watch the meeting in the player above.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
Advisory Board Recommends FDA Approval Of Moderna COVID Vaccine
SILVER SPRINGS, Md. –– An FDA advisory panel is recommending emergency use authorization for a second coronavirus vaccine.
The vaccine by Moderna is expected to get final approval in the next day or so. Trial studies found the two-dose vaccine around 95-percent effective.
With the expectation that the FDA will soon give the green light, vaccine advisers to the CDC scheduled meetings for Saturday and Sunday to discuss the Moderna vaccine.
The group must vote to recommend the vaccine and the CDC must accept that recommendation before vaccinations can begin.
“I think this is a very exciting moment,” Dr. Hayley Gans, a member of the FDA’s vaccine advisory committee, told CNN. “The data that was presented to us was striking in its efficacy.”
Associated Press
FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)
WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.